Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Baxter
Mallinckrodt
AstraZeneca
Moodys
McKesson

Last Updated: November 28, 2021

DrugPatentWatch Database Preview

Vancomycin - Generic Drug Details

➤ Subscribe for complete access

« Back to Dashboard

What are the generic sources for vancomycin and what is the scope of patent protection?

Vancomycin is the generic ingredient in eight branded drugs marketed by Xellia Pharms Aps, Ani Pharms, Akorn, Fresenius Kabi Usa, Lupin Ltd, Orient Pharma Co Ltd, Strides Pharma, Watson Labs, Azurity, Lederle, Baxter Hlthcare, West-ward Pharms Int, Emcure Pharms Ltd, Eugia Pharma, Gland Pharma Ltd, Hainan Poly Pharm, Hikma, Hikma Pharms, Hospira, Hospira Inc, Mylan Labs Ltd, Pharm Assoc, Sagent Pharms, Sandoz, Sandoz Inc, Teva Pharms Usa, Pharmacia And Upjohn, and Samson Medcl, and is included in fifty-three NDAs. There are ten patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Vancomycin has thirty-nine patent family members in twenty-six countries.

There are twenty-two drug master file entries for vancomycin. One supplier is listed for this compound.

Summary for vancomycin
International Patents:39
US Patents:10
Tradenames:8
Applicants:28
NDAs:53
Drug Master File Entries: 22
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 35
Clinical Trials: 385
Patent Applications: 6,762
Drug Prices: Drug price trends for vancomycin
What excipients (inactive ingredients) are in vancomycin?vancomycin excipients list
DailyMed Link:vancomycin at DailyMed
Drug Prices for vancomycin

See drug prices for vancomycin

Drug Sales Revenue Trends for vancomycin

See drug sales revenues for vancomycin

Recent Clinical Trials for vancomycin

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Panhandle Eye Group, LLPPhase 3
Radboud UniversityN/A
University of Texas Southwestern Medical CenterPhase 4

See all vancomycin clinical trials

Pharmacology for vancomycin

US Patents and Regulatory Information for vancomycin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Azurity FIRVANQ KIT vancomycin hydrochloride FOR SOLUTION;ORAL 208910-002 Jan 26, 2018 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial Y ⤷  Free Forever Trial
Xellia Pharms Aps VANCOMYCIN HYDROCHLORIDE vancomycin hydrochloride SOLUTION;INTRAVENOUS 211962-003 Feb 15, 2019 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial Y ⤷  Free Forever Trial
Xellia Pharms Aps VANCOMYCIN vancomycin SOLUTION;INTRAVENOUS, ORAL 213895-001 Aug 26, 2021 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial Y ⤷  Free Forever Trial
Xellia Pharms Aps VANCOMYCIN HYDROCHLORIDE vancomycin hydrochloride INJECTABLE;INJECTION 206243-002 Dec 23, 2015 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Xellia Pharms Aps VANCOMYCIN HYDROCHLORIDE vancomycin hydrochloride SOLUTION;INTRAVENOUS 211962-007 May 13, 2020 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial Y ⤷  Free Forever Trial
Xellia Pharms Aps VANCOMYCIN HYDROCHLORIDE vancomycin hydrochloride SOLUTION;INTRAVENOUS 211962-004 Feb 15, 2019 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial Y ⤷  Free Forever Trial
Sandoz VANCOMYCIN HYDROCHLORIDE vancomycin hydrochloride INJECTABLE;INJECTION 090250-001 Apr 27, 2010 AP RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
Express Scripts
Merck
Medtronic
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.